Dr. Shan Guo, M.D.
What this data tells you about Dr. Guo
Dr. Shan Guo is a hematology & oncology in Houston, TX, with 18 years in practice. Based on federal Medicare data, Dr. Guo performed 80,315 Medicare services across 933 unique beneficiaries.
Between the years covered by Open Payments, Dr. Guo received a total of $20,996 from 69 pharmaceutical and/or device companies across 467 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Guo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 42,750 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 15,400 | $43 | $130 |
| Anti-nausea injection (fosaprepitant) | 9,900 | $0 | $1 |
| Contrast dye for imaging (iodine-based) | 4,200 | $0 | $0 |
| MRI contrast dye injection (gadoterate) | 4,000 | $0 | $0 |
| Dexamethasone injection (steroid) | 1,018 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 770 | $1 | $6 |
| Office visit, established patient (30-39 min) | 511 | $93 | $346 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 336 | $23 | $82 |
| Office visit, established patient, complex (40-54 min) | 273 | $136 | $484 |
| Administration of chemotherapy into vein, 1 hour or less | 193 | $104 | $374 |
| Drug injection, under skin or into muscle | 186 | $11 | $38 |
| Administration of additional new drug or substance into vein, 1 hour or less | 110 | $51 | $183 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 82 | $51 | $179 |
| Administration of chemotherapy into vein, each additional hour | 79 | $23 | $80 |
| Initial hospital admission, high complexity | 65 | $129 | $503 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 59 | $110 | $295 |
| Hospital follow-up visit, high complexity | 58 | $91 | $279 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 57 | $1,181 | $5,599 |
| Injection, diphenhydramine hcl, up to 50 mg | 56 | $1 | $3 |
| Hospital follow-up visit, moderate complexity | 52 | $61 | $198 |
| New patient office visit (45-59 min) | 44 | $134 | $450 |
| Initial hospital admission, moderate complexity | 29 | $99 | $358 |
| Ct scan of chest with contrast | 28 | $56 | $456 |
| CT scan of abdomen and pelvis with contrast | 27 | $174 | $847 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $15 | $62 |
| CT scan of chest, without contrast | 14 | $55 | $322 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (46%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Guo is a mixed practice specialist, with above-average Medicare volume (top 11% in TX), and consulting-driven industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Guo experienced with iron infusion (injectafer)?
Does Dr. Guo receive payments from pharmaceutical companies?
How do Dr. Guo's costs compare to other hematology & oncologys in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology